Ischemic postconditioning: mechanisms, comorbidities, and clinical application
- 13 March 2014
- journal article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 392 (1-2) , 1-12
Abstract
Since ischemic heart disease (IHD) is a major cause of mortality and heart failure, novel therapeutic strategies are expected to improve the clinical outcomes of patients with acute myocardial infarction. Brief episodes of ischemia/reperfusion performed at the onset of reperfusion can reduce infarct size; a phenomenon termed “ischemic postconditioning.” Extensive research has determined that different autacoids (e.g., adenosine, bradykinin, opioid, etc.) and cytokines, their respective receptors, kinase signaling pathways, and mitochondrial modulation are involved in ischemic conditioning. Modification of these factors by pharmacological agents mimics the cardioprotection by ischemic postconditioning. Here, the potential mechanisms of ischemic postconditioning, the presence of comorbidities, and the possible extrapolation to the clinical setting are reviewed. In the near future, large, multicentered, randomized, placebo-controlled, clinical trials will be required to determine whether pharmacological and/or ischemic postconditioning can improve the clinical outcomes of patients with IHD.Keywords
This publication has 87 references indexed in Scilit:
- Diazoxide postconditioning induces mitochondrial protein S-Nitrosylation and a redox-sensitive mitochondrial phosphorylation/translocation of RISK elements: no role for SAFEBasic Research in Cardiology, 2013
- Long-term impact of postconditioning on infarct size and left ventricular ejection fraction in patients with ST-elevation myocardial infarctionBMC Cardiovascular Disorders, 2013
- Activation of cGMP/Protein Kinase G Pathway in Postconditioned Myocardium Depends on Reduced Oxidative Stress and Preserved Endothelial Nitric Oxide Synthase CouplingJournal of the American Heart Association, 2013
- Ischemic postconditioning through percutaneous transluminal coronary angioplasty in pigsCoronary Artery Disease, 2012
- Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioningCardiovascular Diabetology, 2012
- Postconditioning inhibits myocardial apoptosis during prolonged reperfusion via a JAK2-STAT3-Bcl-2 pathwayJournal of Biomedical Science, 2011
- Cardioprotection with Postconditioning: Loss of Efficacy in Murine Models of Type-2 and Type-1 DiabetesAntioxidants & Redox Signaling, 2011
- Type 2 diabetes, mitochondrial biology and the heartJournal of Molecular and Cellular Cardiology, 2009
- The no-reflow phenomenon: A basic mechanism of myocardial ischemia and reperfusionBasic Research in Cardiology, 2006
- Postconditioning attenuates cardiomyocyte apoptosis via inhibition of JNK and p38 mitogen-activated protein kinase signaling pathwaysApoptosis, 2006